Page last updated: 2024-08-24

ziprasidone and Recrudescence

ziprasidone has been researched along with Recrudescence in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (66.67)29.6817
2010's5 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossi, A; Stratta, P1
Han, TY; Kim, EJ; Kim, MS; Kim, SW; Lee, JH; Son, SJ1
Dadić-Hero, E; Knez, R; Medved, P; Petrić, D; Ruzić, K1
Ascher-Svanum, H; Bruhn, D; Graham, CN; Lawson, AH; Mauskopf, JA1
Buchmann, J; Häßler, F; Höppner, J; Pohl, B; Reis, O; Weirich, S1
Akintola, M; Messerschmidt, C; Morewitz, J; Spiegel, DR1
Ghaemi, SN; Rosenquist, KJ; Walker, SS1
Arato, M; Meltzer, HY; O'Connor, R1
Ananth, J; Burgoyne, KS; Niz, D; Smith, M1
Bares, M; Kopecek, M; Mohr, P1
Coffey, B; Jummani, R; Vito, J1
Bernardo, M; Ramón Azanza, J; Rejas, J; Rubio-Terrés, C1
Karanti, A; Landén, M1
Gomberg, R1
Davis, R; Risch, SC1

Trials

1 trial(s) available for ziprasidone and Recrudescence

ArticleYear
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.
    International clinical psychopharmacology, 2002, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome

2002

Other Studies

14 other study(ies) available for ziprasidone and Recrudescence

ArticleYear
Short-term remission in schizophrenia as a combination of several outcome measures.
    Psychiatry research, 2013, Oct-30, Volume: 209, Issue:3

    Topics: Adolescent; Adult; Antipsychotic Agents; Body Mass Index; Cognition Disorders; Female; Humans; Logistic Models; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2013
Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
    International journal of dermatology, 2014, Volume: 53, Issue:4

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Hypersensitivity Syndrome; Female; Humans; Piperazines; Recurrence; Retreatment; Thiazoles

2014
Pregnancy and atypical antipsychotics.
    Psychiatria Danubina, 2009, Volume: 21, Issue:3

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluphenazine; Humans; Infant, Newborn; Piperazines; Pregnancy; Pregnancy Complications; Recurrence; Schizophrenia; Thiazoles

2009
Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2012, Volume: 15, Issue:1

    Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Health Services; Humans; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Schizophrenia; Thiazoles

2012
A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
    Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2013, Volume: 41, Issue:1

    Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Combined Modality Therapy; Creatine Kinase; Dibenzothiazepines; Diseases in Twins; Drug Substitution; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Recurrence; Schizophrenia; Thiazoles

2013
A case of recurrent psychosis during sickle cell disease crisis treated successfully with ziprasidone.
    Clinical schizophrenia & related psychoses, 2013, Volume: 6, Issue:4

    Topics: Adult; Analgesics, Opioid; Anemia, Sickle Cell; Antipsychotic Agents; Blood Transfusion; Diagnosis, Differential; Fluid Therapy; Hospitalization; Humans; Male; Pain; Pain Management; Piperazines; Psychotic Disorders; Recurrence; Thiazoles

2013
Tardive dyskinesia and ziprasidone.
    The American journal of psychiatry, 2002, Volume: 159, Issue:8

    Topics: Antipsychotic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Piperazines; Recurrence; Risk Factors; Thiazoles

2002
Tardive dyskinesia in 2 patients treated with ziprasidone.
    Journal of psychiatry & neuroscience : JPN, 2004, Volume: 29, Issue:6

    Topics: Adult; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Follow-Up Studies; Hallucinations; Humans; Long-Term Care; Male; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles

2004
Ziprasidone-induced galactorrhea: a case report.
    Neuro endocrinology letters, 2005, Volume: 26, Issue:1

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clonazepam; Depressive Disorder, Major; Female; Galactorrhea; Humans; Lithium; Piperazines; Prolactin; Recurrence; Thiazoles

2005
Advanced pediatric psychopharmacology.
    Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal

2006
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain.
    Clinical drug investigation, 2006, Volume: 26, Issue:8

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Models, Econometric; Piperazines; Program Evaluation; Recurrence; Reproducibility of Results; Schizophrenia; Spain; Thiazoles; Time Factors

2006
Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report.
    Psychopharmacology bulletin, 2007, Volume: 40, Issue:1

    Topics: Antipsychotic Agents; Combined Modality Therapy; Comorbidity; Continuous Positive Airway Pressure; Diagnosis, Differential; Drug Resistance; Female; Humans; Middle Aged; Obesity Hypoventilation Syndrome; Piperazines; Recurrence; Schizophrenia, Disorganized; Sleep Apnea Syndromes; Thiazoles

2007
Possible case of allopurinol causing relapse of psychosis.
    Schizophrenia research, 2007, Volume: 93, Issue:1-3

    Topics: Adult; Allopurinol; Antipsychotic Agents; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Hallucinations; Humans; Piperazines; Psychoses, Substance-Induced; Recurrence; Schizophrenia, Paranoid; Thiazoles

2007
Ziprasidone induction of hypomania in depression?
    The American journal of psychiatry, 2002, Volume: 159, Issue:4

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Piperazines; Recurrence; Thiazoles

2002